Trinity Biotech (TRIB) Misses Q3 EPS by 7c

Trinity Biotech (NASDAQ: TRIB) reported Q3 EPS of ($0.16), $0.07 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $13.9 million versus the consensus estimate of $13.5 million.

For earnings history and earnings-related data on Trinity Biotech (TRIB) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 45c
• Alabama Power Co. 5.875% Sr. Notes Series 2007b (ALM) Tops Q2 EPS by 62c